Cell-free Fetal DNA Concentration in Cases of Abnormal Placental Invasion .
NCT ID: NCT03638024
Last Updated: 2018-10-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
50 participants
OBSERVATIONAL
2018-09-01
2019-04-03
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cell-free Fetal DNA Circulating in the Maternal Plasma as a Marker for Morbidly Adherent Placenta
NCT02784886
Free DNA and Nucleosome Concentrations in Pathological Pregnancies
NCT01736826
Evaluation of the Role of Plasma Procalcitonin in Prediction of Intra-amniotic Infection in Preterm Premature Rupture of Membrane
NCT02104791
Urea and Creatinine Level in Vaginal Fluid as a Predicator for Length of Latency Period in Prelabour Membranes Rupture
NCT03213535
Anxiety and Depressive Symptoms in Placenta Previa / Accreta
NCT05529381
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Study group
Maternal plasma cell free fetal DNA levels will be measured in 25 women with one or more previous cesarean section and placenta previa anterior only or with ultrasound finding suggestive of placental adhesion or invasion (accreta , increta or percreta).
Maternal plasma cell free fetal DNA levels
Measurement Maternal plasma cell free fetal DNA levels in both groups (study and control groups)
Control group
Maternal plasma cell free fetal DNA levels will be measured in 25 matched control with normally situated placenta without ultrasound finding suggestive of placental adhesion or invasion.
Maternal plasma cell free fetal DNA levels
Measurement Maternal plasma cell free fetal DNA levels in both groups (study and control groups)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Maternal plasma cell free fetal DNA levels
Measurement Maternal plasma cell free fetal DNA levels in both groups (study and control groups)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Parity: para 1- para 5.
3. Body mass index range from 18-25 kg/m2.
4. Singleton pregnancy carrying male fetuses.
5. Gestational age range from 28-34 weeks.
Exclusion Criteria
2. Hypertension, preterm labor and intrauterine growth restriction.
3. Patients taking a tocolytic agent or those with uterine bleeding at or after blood sampling.
* Since these complications may increase the level of cell-free fetal DNA.
4. Accidental hemorrhage.
20 Years
40 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ain Shams Maternity Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr- dina yahia mansour
Lecturer of Obstetrics and Gynecology Ain Shams University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ain Shams University, Maternity Hospital
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Cell free fetal DNA
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.